These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28570763)

  • 1. Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
    Pisani L; Catto M; De Palma A; Farina R; Cellamare S; Altomare CD
    ChemMedChem; 2017 Aug; 12(16):1349-1358. PubMed ID: 28570763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi-Target-Directed Ligands against Alzheimer's Disease.
    Abdshahzadeh H; Golshani M; Nadri H; Saberi Kia I; Abdolahi Z; Forootanfar H; Ameri A; Tüylü Küçükkılınç T; Ayazgok B; Jalili-Baleh L; Sadat Ebrahimi SE; Moghimi S; Haririan I; Khoobi M; Foroumadi A
    Chem Biodivers; 2019 May; 16(5):e1800436. PubMed ID: 30957958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.
    Montanari S; Bartolini M; Neviani P; Belluti F; Gobbi S; Pruccoli L; Tarozzi A; Falchi F; Andrisano V; Miszta P; Cavalli A; Filipek S; Bisi A; Rampa A
    ChemMedChem; 2016 Jun; 11(12):1296-308. PubMed ID: 26507467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
    Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
    Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
    Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
    Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
    Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A; Saini V; Meena P; Tiwari M
    Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
    Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
    Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
    Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
    Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
    Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
    Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety.
    Ghanei-Nasab S; Khoobi M; Hadizadeh F; Marjani A; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2016 Oct; 121():40-46. PubMed ID: 27214510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
    Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
    Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
    Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
    Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.